Subsartorial Nerve Block and Femoral Nerve Block in Total Knee Arthroplasty
Subsartorial Saphenous Nerve Block (SSNB) Versus Femoral Nerve Block (FNB) in Primary Total Knee Arthroplasty (TKA) Combined With Infiltration Between Popliteal Artery and Capsule of the Knee (IPACK) - Where Are the Benefits?
Luzerner Kantonsspital
144 participants
Nov 30, 2023
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to compare two different types of nerve blocks in patients undergoing surgery for primary Total Knee Arthroplasty. The main question aim to answer is: \- is there a benefit in functional muscle power output of the leg? Participants will be randomized into either the intervention group or the control group and: * receive Subsartorial Saphenous Nerve Block (SSNB) + IPACK in intervention group (group 1) * receive Femoral Nerve Block (FNB) + IPACK in control group (group 2) Researchers will compare the 2 groups to see if there are differences in : * functional muscle power output of the leg? * muscle function, mobility, clinical and radiological results, ROM, pain control (NRS), opioid consumption, length of hospital stay, patient satisfaction, mobility, reduction of costs?
Eligibility
Inclusion Criteria5
- age > 18yrs
- primary TKA
- BMI 35kg/m2 or less
- able to give informed consent as documented by signature
- clinical history without any contraindications for the planned intervention
Exclusion Criteria8
- age < 18 years
- revision-TKA
- BMI >35kg/m2
- absent contact information
- inability or contraindications to undergo the investigated intervention (TKA, FNB, SSNB), - clinically significant concomitant diseases
- pregnancy
- inability to follow the procedures and follow-up procedures of the study (e.g. due to language problems, psychological disorders, dementia, living abroad, etc.
- withdrawal from the study
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
already included in arm/group description
already included in arm/group description
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06074744